We are entrepreneurs at heart and are passionate about building world-class biotechnology companies. Our team consists of talented entrepreneurs that combine a deep knowledge of scientific research, product development, and business development to help position breakthrough science for success. Our passion is your power and we put our insight, experience, and expertise to work in helping you to achieve your goals.
Thong Q. Le
Chief Executive Officer
Kendall Mohler, Ph.D.
Chief Development Officer
Ian A.W. Howes
Chief Financial Officer
Court R. Turner, JD
Chief Business Officer
Alice Chen, Ph.D.
Vice President
Merika Koday, Ph.D.
Associate
Suzanne Rettenmier
Controller
Jessica Burback
Chief of Staff
Our Directors have extensive expertise in the biotechnology and pharmaceutical industries, and they know from personal experience what it takes to finance and operate a successful life science company. They believe in the power of innovative science to radically improve human health and are dedicated to supporting us in our mission to turn today’s scientific discoveries into tomorrow’s breakthrough products.
Dr. Michael Baran
Pfizer Ventures
Dr. Bruce Carter
Director
Margarita Chavez
AbbVie Ventures
M. Johnston Erwin, Jr.
Eli Lilly and Company
Dr. Steven Gillis
ARCH Venture Partners
Dr. Leroy Hood
Director
Sundar Kodiyalam
Director
Thong Q. Le
Accelerator Life Science Partners
Joel S. Marcus
Alexandria Real Estate Equities Inc.
Alexandria Venture Investments
Dr. Asish K. Xavier
Johnson & Johnson Development Corporation
Dr. Tadataka Yamada
Director
Our Operating Partners leverage their years of experience in specific areas of expertise to identify new investment areas and specific company-building opportunities. They also support the management and scientific oversight of our portfolio companies, helping you to reach your innovative potential.
Kevin Chow, Ph.D.
(Seattle, WA)
Stephen Gwaltney, Ph.D.
(Chapel Hill, NC)
Andrew Howard, Ph.D.
(New York, NY)
Wendy S. Johnson
(San Diego, CA)
David L. Pompliano, Ph.D.
(New York, NY)
Francisco D. Salva
(Philadelphia, PA)
John T. Santini, Jr., Ph.D.
(Minneapolis, MN)
Christopher Toombs, Ph.D.
(Seattle, WA)
David M. Schubert
(Houston, TX)
Court R. Turner, J.D.
(San Diego, CA)
Leslie J. Williams
(Boston, MA)
Melissa A. Yeager, J.D.
(Seattle, WA)
Transforming a breakthrough scientific idea into an innovative product takes more than robust data. Our clinical and scientific advisors support the complete spectrum of product development activities, providing critical insights into preclinical research, clinical trial design and strategy and regulatory pathways.
Lee E. Babiss, Ph.D.
Scott Brun, M.D.
David Hirsh, Ph.D.
John Latham, Ph.D.
Jan M. Lundberg, Ph.D.
George L. McLendon, Ph.D.
Kendall M. Mohler, Ph.D.
Gerald T. Nepom, M.D., Ph.D.
Homer L. Pearce, Ph.D.
Anil K. Singhal, Ph.D.
Bruce Carter, Ph.D.
Steven Gillis, Ph.D.
Leroy Hood, Ph.D.
Sundar Kodiyalam
Jan M. Lundberg, Ph.D.
Tadataka Yamada, Ph.D.
